Since 2022 the United States has had a federal framework for cosmetics that looks more like the European one than the previous arrangement did. For buyers entering the US market, the practical effect is a set of filings and named responsibilities that exist independently of whether the product is imported or made domestically. This note sets out what the framework requires, in the order a first order usually meets it.
What changed, in one paragraph
Cosmetics in the US are still not subject to pre-market approval. What the 2022 amendments introduced is registration and listing, a named responsible person, mandatory adverse event reporting, and a route to mandatory good manufacturing practice. In other words: the product does not need a licence to be sold, but the facility and the product have to be on file, and someone has to be answerable.
Facility registration
Facilities that manufacture or process cosmetic products for US distribution must register with the FDA, and the registration has to be renewed on a two-year cycle. The registration identifies the facility and its operations; it is not an approval of anything the facility makes.
Two practical points come up on first orders. Registration sits with the facility that manufactures or processes the product, not with the brand that sells it — so a brand importing from a contract manufacturer is relying on that manufacturer’s registration. And where a facility changes ownership or address, the registration has to follow the change rather than being left in the previous holder’s name.
Product listing
Each cosmetic product must be listed, with the responsible person identified and the product’s ingredients disclosed to the FDA. Listings are updated annually, and a new product needs a listing before or as it enters distribution rather than at some later convenience.
This is the step most often confused with the European notification. They are not the same filing, and satisfying one does not satisfy the other. The EU route is described in what an EU distributor must hold; a product sold in both markets needs both.
The responsible person
The framework requires a named responsible person for each product — an entity with a US address that carries the obligations attached to it, including responding to FDA requests and maintaining records. For an imported product this is normally the US-based brand owner or importer, not the overseas factory.
This is the point where a supply relationship has to be explicit. A factory can supply documentation, but it cannot be the US responsible person for a brand it does not own. Buyers who assume the factory handles it usually discover otherwise at the point of a listing or an adverse event, which is the worst moment to discover it.
Adverse event reporting and records
Serious adverse events associated with a cosmetic product must be reported to the FDA within 15 business days of the responsible person becoming aware of them, with follow-up reporting for new information. Records supporting those reports have to be kept and made available on request.
In practice this means the brand needs a route for consumer complaints that reaches a person able to judge seriousness, and it needs the batch and distribution information to trace a complaint back to a lot. That is a records design question, not a paperwork question, and it is easier to set up before the first shipment than after the first complaint.
Good manufacturing practice
The FDA has been developing mandatory GMP requirements for cosmetics, which for the first time would make manufacturing practice a regulatory obligation rather than a voluntary standard. Until those requirements take effect, the practical position for a buyer is unchanged: ask what standard the facility works to and ask for evidence of it. Our own facility documentation is described on the private label page, and the commercial questions — quantities, preparation time, terms — are covered in the wholesale FAQ.
What the framework does not do
It does not create a pre-market approval, and it does not license the word “approved”. Saying a cosmetic is FDA approved is a misstatement regardless of how the registration and listing were handled — the filings are registrations, not approvals. This is worth stating plainly because it appears in supplier marketing material often enough that buyers begin to believe it.
It also does not replace labelling rules. Ingredient declaration, net quantity, product identity, and the name and address of the party responsible all still apply, and the US does not require the European period-after-opening symbol or a mandatory durability date in the same way. The elements themselves are set out in what must appear on a cosmetic pack.
Smaller businesses should check whether they fall within the exemption thresholds for registration and listing, which carry conditions and do not apply to every product category. The exemption is narrow in practice and is not a reason to skip the responsible person question.
Who holds what on a private label order
Split the work before the purchase order, not after it. The factory side holds the site registration, the quality system audit, batch records, a certificate of analysis per batch, the quantitative formula and the INCI list. That document set is described on the factory page, and first-order terms are on the wholesale FAQ.
The brand side holds the responsible person role, the product listing, the adverse event file, the US agent arrangement where a foreign facility needs one, and the final label approval. If you are building the brand rather than buying wholesale, the split is set out under private label; if you are distributing an existing brand, start at the distributor pages, including the regional page for Europe where shipments are split between markets.
A short checklist for a first US order
- Which facility manufactures, and is its registration current?
- Who is the responsible person, with a US address?
- Has the product been listed, and when is the annual update due?
- Who receives consumer complaints, and how is seriousness judged?
- Can a complaint be traced to a batch and a distribution list?
- Does any label or marketing text say “FDA approved”?
None of these are difficult to answer once someone owns them. The cost of leaving them unanswered is not a fine on day one — it is discovering at the first complaint that nobody can produce the record.
Leave a Reply